These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 22646866)

  • 1. Effect of very early treatment in rheumatoid arthritis on bone oedema and synovitis, using magnetic resonance imaging.
    Kosta PE; Voulgari PV; Zikou AK; Tsampoulas K; Drosos AA; Argyropoulou MI
    Scand J Rheumatol; 2012 Oct; 41(5):339-44. PubMed ID: 22646866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission.
    Lisbona MP; Pàmies A; Ares J; Almirall M; Navallas M; Solano A; Maymó J
    J Rheumatol; 2014 Aug; 41(8):1623-9. PubMed ID: 24986851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are rheumatoid arthritis patients discernible from other early arthritis patients using 1.5T extremity magnetic resonance imaging? a large cross-sectional study.
    Stomp W; Krabben A; van der Heijde D; Huizinga TW; Bloem JL; van der Helm-van Mil AH; Reijnierse M
    J Rheumatol; 2014 Aug; 41(8):1630-7. PubMed ID: 25028382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
    Forslind K; Svensson B
    Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow edema is the most specific finding for rheumatoid arthritis (RA) on noncontrast magnetic resonance imaging of the hands and wrists: a comparison of patients with RA and healthy controls.
    Olech E; Crues JV; Yocum DE; Merrill JT
    J Rheumatol; 2010 Feb; 37(2):265-74. PubMed ID: 19955056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
    Axelsen MB; Eshed I; Hørslev-Petersen K; Stengaard-Pedersen K; Hetland ML; Møller J; Junker P; Pødenphant J; Schlemmer A; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Krogh NS; Johansen JS; Østergaard M;
    Ann Rheum Dis; 2015 May; 74(5):867-75. PubMed ID: 24412895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
    Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
    Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis.
    Conaghan PG; O'Connor P; McGonagle D; Astin P; Wakefield RJ; Gibbon WW; Quinn M; Karim Z; Green MJ; Proudman S; Isaacs J; Emery P
    Arthritis Rheum; 2003 Jan; 48(1):64-71. PubMed ID: 12528105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study.
    Palosaari K; Vuotila J; Takalo R; Jartti A; Niemelä RK; Karjalainen A; Haapea M; Soini I; Tervonen O; Hakala M
    Rheumatology (Oxford); 2006 Dec; 45(12):1542-8. PubMed ID: 16670155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis.
    Yu X; Wang L; Xu P; Lu W; Lan G; Ping L; Wang X; Tian J; Liu J
    J Rheumatol; 2012 Jun; 39(6):1171-8. PubMed ID: 22505700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI.
    Gandjbakhch F; Foltz V; Mallet A; Bourgeois P; Fautrel B
    Ann Rheum Dis; 2011 Dec; 70(12):2159-62. PubMed ID: 21859693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients.
    Østergaard M; Emery P; Conaghan PG; Fleischmann R; Hsia EC; Xu W; Rahman MU
    Arthritis Rheum; 2011 Dec; 63(12):3712-22. PubMed ID: 22127693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Magnetic resonance imaging evaluation of early rheumatoid arthritis of hand and wrist].
    Zhang HB; Liu M; Wang L; Jiang T; Si LF; Zhai RY; Bai RJ
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(45):3598-601. PubMed ID: 24534310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis.
    Tan AL; Tanner SF; Conaghan PG; Radjenovic A; O'Connor P; Brown AK; Emery P; McGonagle D
    Arthritis Rheum; 2003 May; 48(5):1214-22. PubMed ID: 12746894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.
    Haavardsholm EA; Østergaard M; Hammer HB; Bøyesen P; Boonen A; van der Heijde D; Kvien TK
    Ann Rheum Dis; 2009 Oct; 68(10):1572-9. PubMed ID: 19019893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of magnetic resonance imaging of the hand and wrist in very early rheumatoid arthritis.
    Kosta PE; Voulgari PV; Zikou AK; Drosos AA; Argyropoulou MI
    Arthritis Res Ther; 2011 Jun; 13(3):R84. PubMed ID: 21658223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging.
    Axelsen MB; Ejbjerg BJ; Hetland ML; Skjødt H; Majgaard O; Lauridsen UB; Hørslev-Petersen K; Boesen M; Kubassova O; Bliddal H; Østergaard M
    Scand J Rheumatol; 2014; 43(2):109-18. PubMed ID: 24191910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.
    Conaghan PG; Emery P; Østergaard M; Keystone EC; Genovese MC; Hsia EC; Xu W; Rahman MU
    Ann Rheum Dis; 2011 Nov; 70(11):1968-74. PubMed ID: 21784729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.